Hyperbaric Oxygen Therapy for Severe Anemia (Exceptional Blood Loss)
HBOT is FDA-cleared for severe anemia when a transfusion is not possible. Learn how dissolved plasma oxygen bridges tissue oxygen delivery in the hospital.
Emergency: Severe blood loss is a hospital emergency. Call 911 or get to an emergency room. HBOT for severe anemia is given inside a hospital by a care team. It is not something to arrange yourself at a standalone clinic.
HBOT is FDA-cleared for severe anemia, the indication clinicians often call exceptional blood loss anemia. It is not a routine treatment for chronic or iron-deficiency anemia. It belongs to a narrow situation: a patient has lost so much blood that tissues are starving for oxygen, and a transfusion cannot be given.
A transfusion is the standard answer to severe blood loss. When it is on the table, it is used. HBOT enters the picture only when transfusion is refused or impossible, and even then it works as a bridge while the body and the medical team try to restore the blood supply.
When a Transfusion Is Not an Option
Most people who lose a dangerous amount of blood receive donor blood. A handful of situations close that door.
The clearest is faith-based refusal. Jehovah’s Witnesses and some other patients decline transfusion of whole blood and primary blood components on religious grounds, and that choice stands even in an emergency. A second situation is a missing match. Patients with rare blood types, or with antibodies built up from past transfusions or pregnancies, can be impossible to cross-match quickly. A third is supply outpacing what is available, such as massive hemorrhage during trauma or surgery where bleeding moves faster than the blood bank can keep up.
In each case the problem is the same. There are too few red cells to carry oxygen, and the usual fix is off the table. That is the gap HBOT is cleared to fill, for a limited time, under hospital supervision.
How Oxygen Reaches Tissue Without Red Cells
Almost all the oxygen your body delivers normally rides on hemoglobin inside red blood cells. Only a small fraction travels dissolved in the liquid plasma. At normal air pressure that dissolved share is far too little to keep tissues alive on its own.
Pressure changes the math. Breathing pure oxygen at about 3 ATA drives roughly 6 mL of oxygen into solution in every 100 mL of plasma, which is close to what tissues pull from the blood at rest. That is the physiology Boerema and colleagues demonstrated in their 1960 study titled Life Without Blood, in which animals survived with their red cells almost entirely removed while breathing oxygen under pressure. The dissolved oxygen alone carried them.
This is the same principle that makes HBOT the primary treatment for carbon monoxide poisoning, where hemoglobin is present but blocked. In severe anemia the hemoglobin is largely gone instead of blocked, and the dissolved oxygen substitutes for what the missing red cells would have carried. For a fuller picture of the underlying mechanism, see how HBOT works.
The catch is that the effect lasts only while the patient is in the chamber at pressure. Once the session ends, dissolved oxygen falls back to a small fraction. So HBOT for anemia is delivered in intermittent sessions that buy time, not a continuous fix.
What the Evidence Shows
The term exceptional blood loss anemia traces back to Hart, who described treating it with hyperbaric oxygen in JAMA in 1974 (PMID: 4406342). Since then the published record has grown mostly through case reports and small series rather than large randomized trials. That limitation is built into the situation. You cannot ethically randomize a bleeding patient who has refused or cannot receive blood to no treatment.
Van Meter (2005) reviewed the body of evidence in a systematic analysis and concluded that hyperbaric oxygen can serve as a useful adjunct in severe anemia when transfusion is not available, while noting that the evidence rests on case material rather than controlled trials (PMID: 15796315). The Undersea and Hyperbaric Medical Society lists severe anemia among its accepted indications on that basis.
What the evidence does not claim is that HBOT corrects the anemia. It does not make red cells. It keeps oxygen reaching the brain, heart, and other organs during the dangerous window while clinicians control the bleeding and the marrow, often helped by iron and erythropoietin, starts to rebuild the red cell supply.
What Treatment Looks Like
This is inpatient, specialist-directed care. A patient receiving HBOT for severe anemia is already in a hospital, usually in or near an intensive care setting, with a team managing the bleeding, fluids, and overall condition at the same time.
Sessions are scheduled around how the patient is doing, and the hyperbaric medicine physician sets the pressure, length, and frequency. Between sessions the team works on the root problem: stopping the source of blood loss, supporting clotting, and stimulating the body to make new red cells. HBOT is one part of that combined effort, timed to cover the worst of the oxygen shortfall.
Because severe anemia from acute blood loss is an FDA-cleared indication, treatment in this setting may be covered the way other medically necessary hospital care is. Coverage rules change and vary by plan, so the hospital billing team is the place to confirm specifics.
Why This Is Not a Treatment for Chronic Anemia
It is worth being plain about the boundary. If you have iron-deficiency anemia, anemia of chronic kidney disease, or another long-standing low blood count, HBOT is not the answer, and no honest clinic will offer it for that. Those conditions are treated by finding and fixing the cause, replacing iron or other deficient nutrients, and sometimes using medications that prompt red cell production.
The FDA clearance is narrow on purpose. It covers the acute, life-threatening scenario where blood is needed now and cannot be given. Outside that scenario, HBOT for anemia has no established role. You can see where it sits among the other FDA-cleared conditions HBOT treats, and if you are new to the therapy, start with what HBOT is.
Frequently Asked Questions
Is HBOT FDA-approved for severe anemia?
Yes. Severe anemia, often called exceptional blood loss anemia, is one of the conditions cleared by the FDA and listed by the Undersea and Hyperbaric Medical Society. It is used in the hospital when a transfusion cannot be given.
Can HBOT replace a blood transfusion?
No. Transfusion is the standard treatment for severe blood loss. HBOT is a temporizing bridge used only when transfusion is refused or unavailable, and it supports the patient while the blood supply is rebuilt.
How does oxygen reach tissue without red blood cells?
At about 3 ATA, enough oxygen dissolves directly into the plasma to meet resting tissue needs without much hemoglobin. Boerema and colleagues demonstrated this principle in 1960.
Is HBOT used for chronic anemia like iron deficiency?
No. HBOT for anemia is reserved for acute, life-threatening blood loss in a hospital setting. Chronic anemia is managed with iron, diet, and treatment of the underlying cause, not with hyperbaric oxygen.
References
Hart GB. Exceptional blood loss anemia. Treatment with hyperbaric oxygen. JAMA. 1974;228(8):1028-1029. PMID: 4406342
Van Meter KW. A systematic review of the application of hyperbaric oxygen in the treatment of severe anemia: an evidence-based approach. Undersea Hyperb Med. 2005;32(1):61-83. PMID: 15796315
Boerema I, et al. Life without blood. J Cardiovasc Surg (Torino). 1960;1:133-146.
Undersea and Hyperbaric Medical Society. Hyperbaric Oxygen Therapy Indications, 15th Edition (2023). Severe Anemia.
Medical Disclaimer: This page is for informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before pursuing any medical treatment.